276 related articles for article (PubMed ID: 18714113)
21. Effectiveness of a Clinical Pharmacist Medication Therapy Management Program in Discontinuation of Drugs to Avoid in the Elderly.
Caffiero N; Delate T; Ehizuelen MD; Vogel K
J Manag Care Spec Pharm; 2017 May; 23(5):525-531. PubMed ID: 28448783
[TBL] [Abstract][Full Text] [Related]
22. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
[No Abstract] [Full Text] [Related]
23. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
[TBL] [Abstract][Full Text] [Related]
24. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
[TBL] [Abstract][Full Text] [Related]
25. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
[TBL] [Abstract][Full Text] [Related]
26. A new ballgame: comprehensive medication review.
McSpadden C
Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
[TBL] [Abstract][Full Text] [Related]
27. Survey of medication therapy management programs under Medicare part D.
Touchette DR; Burns AL; Bough MA; Blackburn JC
J Am Pharm Assoc (2003); 2006; 46(6):683-91. PubMed ID: 17176683
[TBL] [Abstract][Full Text] [Related]
28. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
[TBL] [Abstract][Full Text] [Related]
29. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
[TBL] [Abstract][Full Text] [Related]
30. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
;
J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
[TBL] [Abstract][Full Text] [Related]
31. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format.
Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K
J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816
[TBL] [Abstract][Full Text] [Related]
32. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians.
Lauffenburger JC; Vu MB; Burkhart JI; Weinberger M; Roth MT
Am J Geriatr Pharmacother; 2012 Apr; 10(2):129-38. PubMed ID: 22284582
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with medication-related problems in an ambulatory medicare population and the case for medication therapy management.
Rogan EL; Ranson CA; Valle-Oseguera CS; Lee C; Gumberg A; Nagin BN; Cao W; Wang E; Trinh C; Chan K; Samra NK; Hou EW; Patel RA
Res Social Adm Pharm; 2020 Jun; 16(6):783-786. PubMed ID: 31447267
[TBL] [Abstract][Full Text] [Related]
34. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
Shoemaker SJ; Hassol A
J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
[TBL] [Abstract][Full Text] [Related]
35. Perceptions of Medicare Part D enrollees about pharmacists and their role as providers of medication therapy management.
Law AV; Okamoto MP; Brock K
J Am Pharm Assoc (2003); 2008; 48(5):648-53. PubMed ID: 18826904
[TBL] [Abstract][Full Text] [Related]
36. Social needs of dual-enrolled Medicare-Medicaid patients with medication nonadherence in a telehealth medication therapy management program.
Almodóvar AS; Ross E; Nahata MC; Bingham JM
J Manag Care Spec Pharm; 2023 Feb; 29(2):210-215. PubMed ID: 36705284
[No Abstract] [Full Text] [Related]
37. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
Wang J; Hong SH; Meng S; Brown LM
Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
Miller DE; Roane TE; Salo JA; Hardin HC
J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
[TBL] [Abstract][Full Text] [Related]
39. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
Murugappan MN; Seifert RD; Farley JF
J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
